Abstract:Reactive oxygen species (ROS), such as superoxide anions and hydrogen peroxide, are reported to contribute to the dynamic regulation of contractility in various arterial preparations, however, the situation in pressurized, myogenically active resistance arteries is much less clear. In the present study, we have utilized established pharmacological inhibitors of NADPH oxidase activity to examine the potential contribution of ROS to intrinsic myogenic contractility in adult Sprague–Dawley rat resistance arteries and responses to vasoactive agents acting via the endothelium (i.e., acetylcholine, SKA-31) or smooth muscle (i.e., sodium nitroprusside, phenylephrine). In cannulated and pressurized cremaster skeletal muscle and middle cerebral arteries, the NOX inhibitors 2-acetylphenothiazine (2-APT) and VAS2870, selective for NOX1 and NOX2, respectively, evoked concentration-dependent inhibition of basal myogenic tone in a reversible and irreversible manner, respectively, whereas the non-selective inhibitor apocynin augmented myogenic contractility. The vasodilatory actions of 2-APT and VAS2870 occurred primarily via the vascular endothelium and smooth muscle, respectively. Functional responses to established endothelium-dependent and –independent vasoactive agents were largely unaltered in the presence of either 2-APT or apocynin. In cremaster arteries from Type 2 Diabetic (T2D) Goto-Kakizaki rats with endothelial dysfunction, treatment with either 2-APT or apocynin did not modify stimulus-evoked vasoactive responses, but did affect basal myogenic tone. These same NOX inhibitors produced robust inhibition of total NADPH oxidase activity in aortic tissue homogenates from control and T2D rats, and NOX isozymes 1, 2 and 4, along with superoxide dismutase 1, were detected by qPCR in cremaster arteries and aorta from both species. Based on the diverse effects that we observed for established, chemically distinct NOX inhibitors, the functional contribution of vascular NADPH oxidase activity to stimulus-evoked vasoactive signaling in myogenically active, small resistance arteries remains unclear.

Mechanisms Related to No-Induced Motility in Differentiated Rat Aortic Smooth Muscle Cells

The Role of Inos-Derived NO in the Antihypertrophic Actions of B-type Natriuretic Peptide in Neonatal Rat Cardiomyocytes

[Effect of Hyperinsulinism on NO Production in Vascular Smooth Muscle Cells].

Effects of IGF-II on promoting proliferation and regulating nitric oxide synthase gene expression in mouse osteoblast-like cell

Protein Kinase C and Protein Tyrosine Kinase Mediate Lipopolysaccharide- and Cytokine-Induced Nitric Oxide Formation in Vascular Smooth Muscle Cells of Rats

Effects of insulin on proliferation, sene-scence and NO secretion of endothelial progenitor cells

Inhibiting Protein Tyrosine Phosphatase 1B to Improve Regenerative Functions of Endothelial Cells

INHIBITION OF SIGNAL TRANSDUCTION PATHWAYS OF ENDOTHELIN-1-INDUCED PROLIFERATION OF VASCULAR SMOOTH MUSCLE CELLS BY NITRIC OXIDE

The Counteracting Effects of Ang II and Ang-(1-7) on the Function Andgrowth of Insulin-secreting NIT-1 Cells.

Role of the arginine-nitric oxide pathway in the regulation of vascular smooth muscle cell proliferation

Effects of Pharmacological Inhibitors of NADPH Oxidase on Myogenic Contractility and Evoked Vasoactive Responses in Rat Resistance Arteries

Upregulation of Nox4 by TGF 1 Oxidizes SERCA and Inhibits NO in Arterial Smooth Muscle of the Prediabetic Zucker Rat

Abstract 5447: Thromboxane A 2 Receptor Activation Attenuates Insulin Signaling and Angiogenesis by Upregulating Phosphatase PTEN in Cultured Endothelial Cells

Insulin-Mediated Upregulation Of K(Ca)3.1 Channels Promotes Cell Migration And Proliferation In Rat Vascular Smooth Muscle

1010 MONOCYTE CHEMOATTRACTANT PROTEIN-1 MEDIATES ANGIOTENSIN II-INDUCED VASCULAR SMOOTH MUSCLE CELL PROLIFERATION VIA SAPK/JNK AND ERK1/2

Identification of Nitric Oxide As an Endogenous Activator of the AMP-activated Protein Kinase in Vascular Endothelial Cells.

Endothelial Nitric Oxide Synthase-Dependent Tyrosine Nitration Of Prostacyclin Synthase In Diabetes In Vivo

Insulin Modulates Ischemia-Induced Endothelial Progenitor Cell Mobilization and Neovascularization in Diabetic Mice

Ace Inhibitors Enhance Insulin Signaling by Reducing Ptp 1b Protein Abundance and Its Activity in Primary Skeletal Muscle Cells from Type 2 Diabetes

PPARγ–PI3K/AKT–NO Signal Pathway is Involved in Cardiomyocyte Hypertrophy Induced by High Glucose and Insulin

Inhibitory Effect Of D3 Dopamine Receptors On Insulin Receptor Expression And Function In Vascular Smooth Muscle Cells